Author

D. D. A. Thu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

N. T. T. Thuong· 3 shared G. Thwaites· 2 shared N. H. Phu· 2 shared A. J. Vickers· 1 shared B. Javid· 1 shared B. M. Kessler· 1 shared B. T. B. Hanh· 1 shared C. Casals-Pascual· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

N. T. T. Thuong

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

High-throughput phenogenotyping of Mycobacteria tuberculosis clinical strains reveals bacterial determinants of treatment outcomes

S. Stanley, C. N. Spaulding, Q. Liu, M. R. Chase, D. T. M. Ha, P. V. K. Thai, N. H. Lan, D. D. A. Thu, N. L. Quang, J. Brown, N. D. Hicks, X. Wang, M. Marin, N. C. Howard, A. J. Vickers, , S. M. Fortune

This study uses high-throughput phenogenotyping to link Mtb genetic variants to clinical outcomes, identifying bacterial traits associated with treatment failure and transmission.

bioRxiv · Apr 9, 2023 · PreprintMicrobiology

Most-probable number based minimum duration of killing assay for determining the spectrum of rifampicin susceptibility in clinical M. tuberculosis isolates

S. Vijay, H. N. Nhung, N. L. H. Bao, D. D. A. Thu, L. P. T. Trieu, N. H. Phu, G. Thwaites, B. Javid, N. T. T. Thuong

This study introduces an MDK assay to quantify rifampicin susceptibility in M. tuberculosis isolates, showing variation in killing times and correlation with tolerant subpopulations.

Antimicrobial Agents and Chemotherapy · Feb 17, 2021Peer-reviewedMicrobiology

Diagnostic Cerebrospinal Fluid Biomarker Discovery and Validation in Patients with Central Nervous System Infections

T. T. Thanh, C. Casals-Pascual, N. T. H. Ny, N. M. Ngoc, R. Geskus, L. N. T. Nhu, N. T. T. Hong, D. T. Duc, D. D. A. Thu, P. N. Uyen, V. B. Ngoc, L. T. M. Chau, V. X. Quynh, N. H. H. Hanh, N. T. T. Thuong, , L. V. Tan

This study identifies and validates lipocalin 2 (LCN2) as a sensitive and specific biomarker for bacterial meningitis in cerebrospinal fluid.

bioRxiv · Jan 13, 2020 · PreprintMicrobiology